Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 476

1.

Comparing No-Show Rates of Neurology Outpatients with and without Parkinson's Disease: A Real-World Assessment of the Parkinsonian Personality Profile.

Bell JF, Wu Y, Sollinger AB, Muthukattil RJ, Ferrara JM.

J Parkinsons Dis. 2019 Sep 25. doi: 10.3233/JPD-191651. [Epub ahead of print]

PMID:
31594248
2.

Catalytic intramolecular hydroamination of aminoallenes using titanium complexes of chiral, tridentate, dianionic imine-diol ligands.

Sha F, Mitchell BS, Ye CZ, Abelson CS, Reinheimer EW, LeMagueres P, Ferrara JD, Takase MK, Johnson AR.

Dalton Trans. 2019 Jul 2;48(26):9603-9616. doi: 10.1039/c8dt05156a.

PMID:
30778494
3.

GVHD: biology matters.

Ferrara JLM, Chaudhry MS.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):221-227. doi: 10.1182/asheducation-2018.1.221. Review.

PMID:
30504314
4.

GVHD: biology matters.

Ferrara JLM, Chaudhry MS.

Blood Adv. 2018 Nov 27;2(22):3411-3417. doi: 10.1182/bloodadvances.2018020214. Review.

5.

Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.

Groth C, van Groningen LFJ, Matos TR, Bremmers ME, Preijers FWMB, Dolstra H, Reicherts C, Schaap NPM, van Hooren EHG, IntHout J, Masereeuw R, Netea MG, Levine JE, Morales G, Ferrara JL, Blijlevens NMA, van Oosterhout YVJM, Stelljes M, van der Velden WJFM.

Biol Blood Marrow Transplant. 2019 Apr;25(4):712-719. doi: 10.1016/j.bbmt.2018.10.020. Epub 2018 Nov 3.

PMID:
30399420
6.

Microbial metabolite sensor GPR43 controls severity of experimental GVHD.

Fujiwara H, Docampo MD, Riwes M, Peltier D, Toubai T, Henig I, Wu SJ, Kim S, Taylor A, Brabbs S, Liu C, Zajac C, Oravecz-Wilson K, Sun Y, Núñez G, Levine JE, van den Brink MRM, Ferrara JLM, Reddy P.

Nat Commun. 2018 Sep 10;9(1):3674. doi: 10.1038/s41467-018-06048-w.

7.

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

Hartwell MJ, Özbek U, Holler E, Renteria AS, Major-Monfried H, Reddy P, Aziz M, Hogan WJ, Ayuk F, Efebera YA, Hexner EO, Bunworasate U, Qayed M, Ordemann R, Wölfl M, Mielke S, Pawarode A, Chen YB, Devine S, Harris AC, Jagasia M, Kitko CL, Litzow MR, Kröger N, Locatelli F, Morales G, Nakamura R, Reshef R, Rösler W, Weber D, Wudhikarn K, Yanik GA, Levine JE, Ferrara JL.

JCI Insight. 2018 Aug 23;3(16). pii: 124015. doi: 10.1172/jci.insight.124015. eCollection 2018 Aug 23. No abstract available.

8.

Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.

Zhao D, Kim YH, Jeong S, Greenson JK, Chaudhry MS, Hoepting M, Anderson ER, van den Brink MR, Peled JU, Gomes AL, Slingerland AE, Donovan MJ, Harris AC, Levine JE, Ozbek U, Hooper LV, Stappenbeck TS, Ver Heul A, Liu TC, Reddy P, Ferrara JL.

J Clin Invest. 2018 Nov 1;128(11):4970-4979. doi: 10.1172/JCI99261. Epub 2018 Sep 24.

9.

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

Holtan SG, DeFor TE, Panoskaltsis-Mortari A, Khera N, Levine JE, Flowers MED, Lee SJ, Inamoto Y, Chen GL, Mayer S, Arora M, Palmer J, Cutler CS, Arai S, Lazaryan A, Newell LF, Jagasia MH, Pusic I, Wood WA, Renteria AS, Yanik G, Hogan WJ, Hexner E, Ayuk F, Holler E, Bunworasate U, Efebera YA, Ferrara JLM, Pidala J, Howard A, Wu J, Bolaños-Meade J, Ho V, Alousi A, Blazar BR, Weisdorf DJ, MacMillan ML.

Blood Adv. 2018 Aug 14;2(15):1882-1888. doi: 10.1182/bloodadvances.2018017343.

10.

EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, Shaw BE, Flowers ME, Ruutu T, Greinix H, Holler E, Basak G, Duarte RF, Pavletic SZ; EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the “EBMT−NIH (National Institutes of Health)−CIBMTR (Center for International Blood and Marrow Transplant Research) GvHD Task Force”.

Bone Marrow Transplant. 2018 Nov;53(11):1401-1415. doi: 10.1038/s41409-018-0204-7. Epub 2018 Jun 5.

PMID:
29872128
11.

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.

Major-Monfried H, Renteria AS, Pawarode A, Reddy P, Ayuk F, Holler E, Efebera YA, Hogan WJ, Wölfl M, Qayed M, Hexner EO, Wudhikarn K, Ordemann R, Young R, Shah J, Hartwell MJ, Chaudhry MS, Aziz M, Etra A, Yanik GA, Kröger N, Weber D, Chen YB, Nakamura R, Rösler W, Kitko CL, Harris AC, Pulsipher M, Reshef R, Kowalyk S, Morales G, Torres I, Özbek U, Ferrara JLM, Levine JE.

Blood. 2018 Jun 21;131(25):2846-2855. doi: 10.1182/blood-2018-01-822957. Epub 2018 Mar 15.

12.

Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures.

Cassatella D, Howard SR, Acierno JS, Xu C, Papadakis GE, Santoni FA, Dwyer AA, Santini S, Sykiotis GP, Chambion C, Meylan J, Marino L, Favre L, Li J, Liu X, Zhang J, Bouloux PM, Geyter C, Paepe A, Dhillo WS, Ferrara JM, Hauschild M, Lang-Muritano M, Lemke JR, Flück C, Nemeth A, Phan-Hug F, Pignatelli D, Popovic V, Pekic S, Quinton R, Szinnai G, l'Allemand D, Konrad D, Sharif S, Iyidir ÖT, Stevenson BJ, Yang H, Dunkel L, Pitteloud N.

Eur J Endocrinol. 2018 Apr;178(4):377-388. doi: 10.1530/EJE-17-0568. Epub 2018 Feb 1.

13.

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation.

Pidala J, Beato F, Kim J, Betts B, Jim H, Sagatys E, Levine JE, Ferrara JLM, Ozbek U, Ayala E, Davila M, Fernandez HF, Field T, Kharfan-Dabaja MA, Khaira D, Khimani F, Locke FL, Mishra A, Nieder M, Nishihori T, Perez L, Riches M, Anasetti C.

Haematologica. 2018 Mar;103(3):531-539. doi: 10.3324/haematol.2017.171199. Epub 2017 Dec 14.

14.

Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.

Naymagon S, Naymagon L, Wong SY, Ko HM, Renteria A, Levine J, Colombel JF, Ferrara J.

Nat Rev Gastroenterol Hepatol. 2017 Dec;14(12):711-726. doi: 10.1038/nrgastro.2017.126. Epub 2017 Sep 27. Review.

15.

T Cell-Mediated Rejection of Human CD34+ Cells Is Prevented by Costimulatory Blockade in a Xenograft Model.

Oh AL, Mahmud D, Nicolini B, Mahmud N, Senyuk V, Patel PR, Bonetti E, Arpinati M, Ferrara JLM, Rondelli D.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2048-2056. doi: 10.1016/j.bbmt.2017.08.009. Epub 2017 Aug 14.

16.

Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.

Ferrara JL, Smith CM, Sheets J, Reddy P, Serody JS.

J Clin Invest. 2017 Jun 30;127(7):2441-2451. doi: 10.1172/JCI90592. Epub 2017 Jun 5. Review.

17.

MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation.

Stickel N, Hanke K, Marschner D, Prinz G, Köhler M, Melchinger W, Pfeifer D, Schmitt-Graeff A, Brummer T, Heine A, Brossart P, Wolf D, von Bubnoff N, Finke J, Duyster J, Ferrara J, Salzer U, Zeiser R.

Leukemia. 2017 Dec;31(12):2732-2741. doi: 10.1038/leu.2017.137. Epub 2017 May 9.

18.

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

Hartwell MJ, Özbek U, Holler E, Renteria AS, Major-Monfried H, Reddy P, Aziz M, Hogan WJ, Ayuk F, Efebera YA, Hexner EO, Bunworasate U, Qayed M, Ordemann R, Wölfl M, Mielke S, Pawarode A, Chen YB, Devine S, Harris AC, Jagasia M, Kitko CL, Litzow MR, Kröger N, Locatelli F, Morales G, Nakamura R, Reshef R, Rösler W, Weber D, Wudhikarn K, Yanik GA, Levine JE, Ferrara JL.

JCI Insight. 2017 Feb 9;2(3):e89798. doi: 10.1172/jci.insight.89798. Erratum in: JCI Insight. 2018 Aug 23;3(16):.

19.

The Goalposts Have Moved: Can Surgery Residents Meet Updated Quality Benchmarks for Adenoma Detection Rate in Colonoscopy?

Ortolani JB, Tershak DR, Ferrara JJ, Paget CJ 3rd.

Am Surg. 2016 Sep;82(9):835-8.

PMID:
27670573
20.

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.

Holtan SG, Khera N, Levine JE, Chai X, Storer B, Liu HD, Inamoto Y, Chen GL, Mayer S, Arora M, Palmer J, Flowers MED, Cutler CS, Lukez A, Arai S, Lazaryan A, Newell LF, Krupski C, Jagasia MH, Pusic I, Wood W, Renteria AS, Yanik G, Hogan WJ, Hexner E, Ayuk F, Holler E, Watanaboonyongcharoen P, Efebera YA, Ferrara JLM, Panoskaltsis-Mortari A, Weisdorf D, Lee SJ, Pidala J.

Blood. 2016 Nov 10;128(19):2350-2358. doi: 10.1182/blood-2015-09-669846. Epub 2016 Sep 13.

21.

Development of a biomarker scoring system for use in graft-versus-host disease.

Renteria AS, Levine JE, Ferrara JL.

Biomark Med. 2016 Aug;10(8):793-5. doi: 10.2217/bmm-2016-0162. Epub 2016 Jul 14. No abstract available.

22.

Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease.

Renteria AS, Levine JE, Ferrara JLM.

Expert Opin Orphan Drugs. 2016;4(5):469-484. doi: 10.1517/21678707.2016.1166949. Epub 2016 Apr 6.

23.

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Levine JE, Braun TM, Harris AC, Holler E, Taylor A, Miller H, Magenau J, Weisdorf DJ, Ho VT, Bolaños-Meade J, Alousi AM, Ferrara JL; Blood and Marrow Transplant Clinical Trials Network.

Lancet Haematol. 2015 Jan;2(1):e21-9. doi: 10.1016/S2352-3026(14)00035-0. Epub 2014 Dec 23.

24.

Changes in Carboxy Methylation and Tyrosine Phosphorylation of Protein Phosphatase PP2A Are Associated with Epididymal Sperm Maturation and Motility.

Dudiki T, Kadunganattil S, Ferrara JK, Kline DW, Vijayaraghavan S.

PLoS One. 2015 Nov 16;10(11):e0141961. doi: 10.1371/journal.pone.0141961. eCollection 2015.

25.

Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.

Kitko CL, Braun T, Couriel DR, Choi SW, Connelly J, Hoffmann S, Goldstein S, Magenau J, Pawarode A, Reddy P, Schuler C, Yanik GA, Ferrara JL, Levine JE.

Biol Blood Marrow Transplant. 2016 May;22(5):862-8. doi: 10.1016/j.bbmt.2015.11.002. Epub 2015 Nov 6.

26.

All pain, no gain: Tc17 phantoms in GVHD.

Ferrara J.

Blood. 2015 Sep 24;126(13):1525-6. doi: 10.1182/blood-2015-08-661512.

PMID:
26405216
27.

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, Chanswangphuwana C, Efebera YA, Holler E, Litzow M, Ordemann R, Qayed M, Renteria AS, Reshef R, Wölfl M, Chen YB, Goldstein S, Jagasia M, Locatelli F, Mielke S, Porter D, Schechter T, Shekhovtsova Z, Ferrara JL, Levine JE.

Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10. doi: 10.1016/j.bbmt.2015.09.001. Epub 2015 Sep 16.

28.

Rethinking the paradigm: How comparative studies on fatty acid oxidation inform our understanding of T cell metabolism.

Chiaranunt P, Ferrara JL, Byersdorfer CA.

Mol Immunol. 2015 Dec;68(2 Pt C):564-74. doi: 10.1016/j.molimm.2015.07.023. Epub 2015 Sep 8. Review.

PMID:
26359186
29.

Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.

Pawarode A, Mineishi S, Reddy P, Braun TM, Khaled YA, Choi SW, Magenau JM, Harris AC, Connelly JA, Kitko CL, Parkin BL, Goldstein SC, Yanik GA, Levine JE, Ferrara JL, Couriel DR.

Biol Blood Marrow Transplant. 2016 Jan;22(1):54-60. doi: 10.1016/j.bbmt.2015.07.021. Epub 2015 Jul 26.

30.

Quality Metrics in Surgery Resident Performance of Screening Colonoscopy.

Ortolani JB, Zhong X, Tershak DR, Ferrara JJ, Paget CJ.

Am Surg. 2015 Jul;81(7):710-3.

PMID:
26140892
31.

Nursing Staff Develop a Video to Prevent Falls: A Quality Improvement Project.

Silkworth AL, Baker J, Ferrara J, Wagner M, Gevaart M, Morin K.

J Nurs Care Qual. 2016 Jan-Mar;31(1):40-5. doi: 10.1097/NCQ.0000000000000135.

PMID:
26121052
32.

Dynamic multiplanar real time ultrasound guided infraclavicular subclavian vein catheterization.

Zhong X, Hamill M, Collier B, Bradburn E, Ferrara J.

Am Surg. 2015 Jun;81(6):621-5.

PMID:
26031277
33.

Programmed death-1 controls T cell survival by regulating oxidative metabolism.

Tkachev V, Goodell S, Opipari AW, Hao LY, Franchi L, Glick GD, Ferrara JL, Byersdorfer CA.

J Immunol. 2015 Jun 15;194(12):5789-800. doi: 10.4049/jimmunol.1402180. Epub 2015 May 13.

34.

Signal hyperintensity of the callosum after ventriculoperitoneal shunting.

Ferrara JM.

Neurology. 2015 Apr 14;84(15):1609-10. doi: 10.1212/WNL.0000000000001464. No abstract available.

PMID:
25870451
35.

Heterogeneously integrated long-wavelength VCSEL using silicon high contrast grating on an SOI substrate.

Ferrara J, Yang W, Zhu L, Qiao P, Chang-Hasnain CJ.

Opt Express. 2015 Feb 9;23(3):2512-23. doi: 10.1364/OE.23.002512.

PMID:
25836117
36.

Selective nonoperative management of foramen of Winslow hernias.

Ferguson RA, Paget C, Ferrara J.

Am Surg. 2015 Apr;81(4):E141-2. No abstract available.

PMID:
25831158
37.

The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.

Reichenbach DK, Schwarze V, Matta BM, Tkachev V, Lieberknecht E, Liu Q, Koehn BH, Pfeifer D, Taylor PA, Prinz G, Dierbach H, Stickel N, Beck Y, Warncke M, Junt T, Schmitt-Graeff A, Nakae S, Follo M, Wertheimer T, Schwab L, Devlin J, Watkins SC, Duyster J, Ferrara JL, Turnquist HR, Zeiser R, Blazar BR.

Blood. 2015 May 14;125(20):3183-92. doi: 10.1182/blood-2014-10-606830. Epub 2015 Mar 26. Erratum in: Blood. 2016 Sep 1;128(9):1311.

38.

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JL, Jones R, Arora M, Blazar BR, Holtan SG, Jacobsohn D, Pasquini M, Socie G, Antin JH, Levine JE, Weisdorf DJ.

Biol Blood Marrow Transplant. 2015 Apr;21(4):761-7. doi: 10.1016/j.bbmt.2015.01.001. Epub 2015 Jan 10.

39.

Severe cardiomyopathy in the setting of relapsing catastrophic antiphospholipid antibody syndrome.

Suryadevara S, Ferrara J, Gore J, Smith C.

Am J Med. 2015 May;128(5):e13-4. doi: 10.1016/j.amjmed.2014.12.004. Epub 2014 Dec 30. No abstract available.

PMID:
25555546
40.

Improved accuracy of acute graft-versus-host disease staging among multiple centers.

Levine JE, Hogan WJ, Harris AC, Litzow MR, Efebera YA, Devine SM, Reshef R, Ferrara JL.

Best Pract Res Clin Haematol. 2014 Sep-Dec;27(3-4):283-7. doi: 10.1016/j.beha.2014.10.011. Epub 2014 Oct 15. Review.

41.

Management of levodopa-induced jig-like gait disorder with pallidal stimulation.

Ferrara JM, Houghton DJ, Knoop C, Park MC.

Neurol Clin Pract. 2014 Dec;4(6):499-501. doi: 10.1212/CPJ.0000000000000054. No abstract available.

42.

Cellular therapy of the host to prevent GVHD.

Ferrara J.

Blood. 2014 Sep 11;124(11):1703-4. doi: 10.1182/blood-2014-07-590380. No abstract available.

43.

CRPS-related neurogenic edema responsive to dextromethorphan/quinidine.

Ferrara JM.

Pain Med. 2014 Nov;15(11):1981-3. doi: 10.1111/pme.12539. Epub 2014 Aug 19. No abstract available.

PMID:
25139080
44.

Development of a web-based laparoscopic technical skills assessment and testing instrument: a pilot study.

Rudderow J, Bansal J, Wearne S, Lara-Torre E, Paget C, Ferrara J.

J Surg Educ. 2014 Nov-Dec;71(6):e73-8. doi: 10.1016/j.jsurg.2014.07.004. Epub 2014 Aug 7.

PMID:
25127452
45.

Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease.

Glick GD, Rossignol R, Lyssiotis CA, Wahl D, Lesch C, Sanchez B, Liu X, Hao LY, Taylor C, Hurd A, Ferrara JL, Tkachev V, Byersdorfer CA, Boros L, Opipari AW.

J Pharmacol Exp Ther. 2014 Nov;351(2):298-307. doi: 10.1124/jpet.114.218099. Epub 2014 Aug 14.

46.

Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Gatza E, Braun T, Levine JE, Ferrara JL, Zhao S, Wang T, Chang L, Harris A, Pawarode A, Kitko C, Magenau JM, Yanik GA, Couriel DR, Goldstein S, Connelly J, Reddy P, Paczesny S, Choi SW.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1426-34. doi: 10.1016/j.bbmt.2014.05.023. Epub 2014 Jun 2.

47.

Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.

Chang L, Frame D, Braun T, Gatza E, Hanauer DA, Zhao S, Magenau JM, Schultz K, Tokala H, Ferrara JL, Levine JE, Reddy P, Paczesny S, Choi SW.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1407-17. doi: 10.1016/j.bbmt.2014.05.022. Epub 2014 Jun 2.

48.

Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol.

Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, Carter SL, Wu J, Wingard JR, Difronzo NL, Ferrara JL, Giralt S, Madtes DK, Drexler R, White ES, Cooke KR.

Biol Blood Marrow Transplant. 2014 Jun;20(6):858-64. doi: 10.1016/j.bbmt.2014.02.026. Epub 2014 Mar 7.

49.

Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.

Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K, Zhu W, Sporrer D, Hehlgans T, Kreutz M, Holler B, Wolff D, Edinger M, Andreesen R, Levine JE, Ferrara JL, Gessner A, Spang R, Oefner PJ.

Biol Blood Marrow Transplant. 2014 May;20(5):640-5. doi: 10.1016/j.bbmt.2014.01.030. Epub 2014 Jan 31.

50.

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.

Kitko CL, Levine JE, Storer BE, Chai X, Fox DA, Braun TM, Couriel DR, Martin PJ, Flowers ME, Hansen JA, Chang L, Conlon M, Fiema BJ, Morgan R, Pongtornpipat P, Lamiman K, Ferrara JL, Lee SJ, Paczesny S.

Blood. 2014 Jan 30;123(5):786-93. doi: 10.1182/blood-2013-08-520072. Epub 2013 Dec 20.

Supplemental Content

Loading ...
Support Center